José Rafael Romero1, Sarah R Preis, Alexa Beiser, Charles DeCarli, Anand Viswanathan, Sergi Martinez-Ramirez, Carlos S Kase, Philip A Wolf, Sudha Seshadri. 1. From the Department of Neurology (J.R.R., A.B., C.S.K., P.A.W., S.S.), School of Medicine and Department of Biostatistics (S.R.P., A.B.), School of Public Health at Boston University, MA; Department of Neurology, University of California, Davis (C.D.); Department of Neurology, Harvard Medical School, Boston, MA (A.V., S.M.-R.); and NHLBI's Framingham Heart Study, Framingham, MA (J.R.R., S.R.P., A.B., C.S.K., P.A.W., S.S.).
Abstract
BACKGROUND AND PURPOSE: Cerebral microbleeds (CMBs) are associated with increased risk of stroke and poor cognition. Vascular risk factors and medications used for stroke prevention may increase the risk of CMB. We examined the prevalence of CMB and the association of these risk factors with CMB, postulating that risk factors for cerebral amyloid angiopathy would be associated with lobar CMB and markers of hypertensive vasculopathy with deep CMB. METHODS: We include 1965 Framingham Original and Offspring participants (age, 66.5±11.0 years; 54% women) and evaluated the age- and sex-specific prevalence of CMB. We related various vascular and genetic (apolipoprotein E [APOE]) risk factors and medication use to the presence of CMB overall and stratified by brain location (deep, lobar, or mixed). RESULTS: CMBs were observed in 8.8% of participants, being mostly lobar (63%). CMB prevalence increased with age (P<0.0001) and was higher in men (P<0.001). Hypertension increased risk of any CMB, and in deep and mixed locations (P<0.05), and low total cholesterol and APOE ε4 increased risk of lobar CMB (P<0.05). Statin use increased risk of lobar and mixed location CMB (P<0.05). The latter association was not affected by adjustment for cholesterol levels or concomitant medication use. CONCLUSIONS: We observed the expected association of hypertension with deep CMB and low cholesterol and APOE ε4 with lobar CMB. In addition, statin use was independently associated with CMB risk. This potential adverse effect of statin use needs to be examined in other cohorts.
BACKGROUND AND PURPOSE: Cerebral microbleeds (CMBs) are associated with increased risk of stroke and poor cognition. Vascular risk factors and medications used for stroke prevention may increase the risk of CMB. We examined the prevalence of CMB and the association of these risk factors with CMB, postulating that risk factors for cerebral amyloid angiopathy would be associated with lobar CMB and markers of hypertensive vasculopathy with deep CMB. METHODS: We include 1965 Framingham Original and Offspring participants (age, 66.5±11.0 years; 54% women) and evaluated the age- and sex-specific prevalence of CMB. We related various vascular and genetic (apolipoprotein E [APOE]) risk factors and medication use to the presence of CMB overall and stratified by brain location (deep, lobar, or mixed). RESULTS:CMBs were observed in 8.8% of participants, being mostly lobar (63%). CMB prevalence increased with age (P<0.0001) and was higher in men (P<0.001). Hypertension increased risk of any CMB, and in deep and mixed locations (P<0.05), and low total cholesterol and APOE ε4 increased risk of lobar CMB (P<0.05). Statin use increased risk of lobar and mixed location CMB (P<0.05). The latter association was not affected by adjustment for cholesterol levels or concomitant medication use. CONCLUSIONS: We observed the expected association of hypertension with deep CMB and low cholesterol and APOE ε4 with lobar CMB. In addition, statin use was independently associated with CMB risk. This potential adverse effect of statin use needs to be examined in other cohorts.
Entities:
Keywords:
cerebral small vessel disease; epidemiology; risk factors
Authors: Tom Jeerakathil; Philip A Wolf; Alexa Beiser; John K Hald; Rhoda Au; Carlos S Kase; Joseph M Massaro; Charles DeCarli Journal: Stroke Date: 2004-05-20 Impact factor: 7.914
Authors: Renske G Wieberdink; Mariëlle M F Poels; Meike W Vernooij; Peter J Koudstaal; Albert Hofman; Aad van der Lugt; Monique M B Breteler; M Arfan Ikram Journal: Arterioscler Thromb Vasc Biol Date: 2011-09-15 Impact factor: 8.311
Authors: Meike W Vernooij; Mendel D M Haag; Aad van der Lugt; Albert Hofman; Gabriel P Krestin; Bruno H Stricker; Monique M B Breteler Journal: Arch Neurol Date: 2009-04-13
Authors: Steven M Greenberg; Meike W Vernooij; Charlotte Cordonnier; Anand Viswanathan; Rustam Al-Shahi Salman; Steven Warach; Lenore J Launer; Mark A Van Buchem; Monique Mb Breteler Journal: Lancet Neurol Date: 2009-02 Impact factor: 44.182
Authors: Reisa Sperling; Stephen Salloway; David J Brooks; Donatella Tampieri; Jerome Barakos; Nick C Fox; Murray Raskind; Marwan Sabbagh; Lawrence S Honig; Anton P Porsteinsson; Ivan Lieberburg; H Michael Arrighi; Kristen A Morris; Yuan Lu; Enchi Liu; Keith M Gregg; H Robert Brashear; Gene G Kinney; Ronald Black; Michael Grundman Journal: Lancet Neurol Date: 2012-02-03 Impact factor: 44.182
Authors: Alessandro Biffi; Akshata Sonni; Christopher D Anderson; Brett Kissela; Jeremiasz M Jagiella; Helena Schmidt; Jordi Jimenez-Conde; Björn M Hansen; Israel Fernandez-Cadenas; Lynelle Cortellini; Alison Ayres; Kristin Schwab; Karol Juchniewicz; Andrzej Urbanik; Natalia S Rost; Anand Viswanathan; Thomas Seifert-Held; Eva-Maria Stoegerer; Marta Tomás; Raquel Rabionet; Xavier Estivill; Devin L Brown; Scott L Silliman; Magdy Selim; Bradford B Worrall; James F Meschia; Joan Montaner; Arne Lindgren; Jaume Roquer; Reinhold Schmidt; Steven M Greenberg; Agnieszka Slowik; Joseph P Broderick; Daniel Woo; Jonathan Rosand Journal: Ann Neurol Date: 2010-12 Impact factor: 10.422
Authors: Jonathan Graff-Radford; Timothy G Lesnick; Michelle M Mielke; Eleni Constantopoulos; Alejandro A Rabinstein; Scott A Przybelski; Prashanthi Vemuri; Hugo Botha; David T Jones; Vijay K Ramanan; Ronald C Petersen; David S Knopman; Bradley F Boeve; Melissa E Murray; Dennis W Dickson; Clifford R Jack; Kejal Kantarci; R Ross Reichard Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: José R Romero; Sarah R Preis; Alexa Beiser; Jayandra J Himali; Ashkan Shoamanesh; Philip A Wolf; Carlos S Kase; Ramachandran S Vasan; Charles DeCarli; Sudha Seshadri Journal: Stroke Date: 2017-01-31 Impact factor: 7.914